These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25256292)

  • 1. TRPV4 channel activity is modulated by direct interaction of the ankyrin domain to PI(4,5)P₂.
    Takahashi N; Hamada-Nakahara S; Itoh Y; Takemura K; Shimada A; Ueda Y; Kitamata M; Matsuoka R; Hanawa-Suetsugu K; Senju Y; Mori MX; Kiyonaka S; Kohda D; Kitao A; Mori Y; Suetsugu S
    Nat Commun; 2014 Sep; 5():4994. PubMed ID: 25256292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structural changes of the mutated ankyrin repeat domain of the human TRPV4 channel alter its ATP binding ability.
    Li D; Kao TH; Chang SW
    J Mech Behav Biomed Mater; 2020 Jan; 101():103407. PubMed ID: 31493693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and biochemical consequences of disease-causing mutations in the ankyrin repeat domain of the human TRPV4 channel.
    Inada H; Procko E; Sotomayor M; Gaudet R
    Biochemistry; 2012 Aug; 51(31):6195-206. PubMed ID: 22702953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Channelopathies converge on TRPV4.
    Nilius B; Owsianik G
    Nat Genet; 2010 Feb; 42(2):98-100. PubMed ID: 20104247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C.
    Auer-Grumbach M; Olschewski A; Papić L; Kremer H; McEntagart ME; Uhrig S; Fischer C; Fröhlich E; Bálint Z; Tang B; Strohmaier H; Lochmüller H; Schlotter-Weigel B; Senderek J; Krebs A; Dick KJ; Petty R; Longman C; Anderson NE; Padberg GW; Schelhaas HJ; van Ravenswaaij-Arts CM; Pieber TR; Crosby AH; Guelly C
    Nat Genet; 2010 Feb; 42(2):160-4. PubMed ID: 20037588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRPV4-pathy, a novel channelopathy affecting diverse systems.
    Dai J; Cho TJ; Unger S; Lausch E; Nishimura G; Kim OH; Superti-Furga A; Ikegawa S
    J Hum Genet; 2010 Jul; 55(7):400-2. PubMed ID: 20505684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism for phosphoinositide selectivity and activation of TRPV1 ion channels.
    Ufret-Vincenty CA; Klein RM; Collins MD; Rosasco MG; Martinez GQ; Gordon SE
    J Gen Physiol; 2015 May; 145(5):431-42. PubMed ID: 25918361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular determinants of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) binding to transient receptor potential V1 (TRPV1) channels.
    Poblete H; Oyarzún I; Olivero P; Comer J; Zuñiga M; Sepulveda RV; Báez-Nieto D; González Leon C; González-Nilo F; Latorre R
    J Biol Chem; 2015 Jan; 290(4):2086-98. PubMed ID: 25425643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient receptor potential melastatin 3 is a phosphoinositide-dependent ion channel.
    Badheka D; Borbiro I; Rohacs T
    J Gen Physiol; 2015 Jul; 146(1):65-77. PubMed ID: 26123195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voltage- and temperature-dependent activation of TRPV3 channels is potentiated by receptor-mediated PI(4,5)P2 hydrolysis.
    Doerner JF; Hatt H; Ramsey IS
    J Gen Physiol; 2011 Mar; 137(3):271-88. PubMed ID: 21321070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRPV4-mediated channelopathies.
    Verma P; Kumar A; Goswami C
    Channels (Austin); 2010; 4(4):319-28. PubMed ID: 20676052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between the Linker, Pre-S1, and TRP Domains Determines Folding, Assembly, and Trafficking of TRPV Channels.
    Garcia-Elias A; Berna-Erro A; Rubio-Moscardo F; Pardo-Pastor C; Mrkonjić S; Sepúlveda RV; Vicente R; González-Nilo F; Valverde MA
    Structure; 2015 Aug; 23(8):1404-1413. PubMed ID: 26146187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the human TRPV2 channel ankyrin repeat domain.
    McCleverty CJ; Koesema E; Patapoutian A; Lesley SA; Kreusch A
    Protein Sci; 2006 Sep; 15(9):2201-6. PubMed ID: 16882997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of the N-terminal ankyrin repeat domain of TRPV3 reveals unique conformation of finger 3 loop critical for channel function.
    Shi DJ; Ye S; Cao X; Zhang R; Wang K
    Protein Cell; 2013 Dec; 4(12):942-50. PubMed ID: 24248473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C.
    Landouré G; Zdebik AA; Martinez TL; Burnett BG; Stanescu HC; Inada H; Shi Y; Taye AA; Kong L; Munns CH; Choo SS; Phelps CB; Paudel R; Houlden H; Ludlow CL; Caterina MJ; Gaudet R; Kleta R; Fischbeck KH; Sumner CJ
    Nat Genet; 2010 Feb; 42(2):170-4. PubMed ID: 20037586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnolol alleviates pulmonary fibrosis inchronic obstructive pulmonary disease by targeting transient receptor potential vanilloid 4-ankyrin repeat domain.
    Niu L; Lu YJ; Zu XW; Yang W; Shen FK; Xu YY; Jiang M; Xie Y; Li SY; Gao J; Bai G
    Phytother Res; 2023 Sep; 37(9):4282-4297. PubMed ID: 37282760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural analyses of the ankyrin repeat domain of TRPV6 and related TRPV ion channels.
    Phelps CB; Huang RJ; Lishko PV; Wang RR; Gaudet R
    Biochemistry; 2008 Feb; 47(8):2476-84. PubMed ID: 18232717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of TRPV1 ion channel by phosphoinositide (4,5)-bisphosphate: the role of membrane asymmetry.
    Senning EN; Collins MD; Stratiievska A; Ufret-Vincenty CA; Gordon SE
    J Biol Chem; 2014 Apr; 289(16):10999-11006. PubMed ID: 24599956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Basis of TRPV4 N Terminus Interaction with Syndapin/PACSIN1-3 and PIP
    Goretzki B; Glogowski NA; Diehl E; Duchardt-Ferner E; Hacker C; Gaudet R; Hellmich UA
    Structure; 2018 Dec; 26(12):1583-1593.e5. PubMed ID: 30244966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mutations highlight the key role of the ankyrin repeat domain in TRPV4-mediated neuropathy.
    Sullivan JM; Zimanyi CM; Aisenberg W; Bears B; Chen DH; Day JW; Bird TD; Siskind CE; Gaudet R; Sumner CJ
    Neurol Genet; 2015 Dec; 1(4):e29. PubMed ID: 27066566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.